Hefei, China · Founded 2019 · Privately Held (backing)
Developer of genetic modification technologies intended for therapeutic applications in ophthalmic disorders. Starry Gene is based in Hefei, China and was founded in 2019. Its last reported valuation was $11.9 million in Nov 2020. It has raised $4.5 million.
Last reported valuation
$11.9M
Oct 2026
Priced at
—
Total raised
$4.5M
Last round
—
Team — not yet on record
No current team members for Starry Gene are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Starry Gene with a free account
·Watch Starry Gene: the Monday email on marks, rounds and moves
